FDA Approved First At Home Nasal Spray Flu Vaccine Increases Accessiblity For Families
The FDA has approved FluMist, a nasal spray flu vaccine, for self-administration in individuals aged 2 to 49, enhancing the convenience of flu immunization. Initially approved in 2003 for ages 5 to 49 and expanded to ages 2 to 5 in 2007, FluMist offers a needle free vaccination utilizing a weakened live virus. It will
FDA Approved First At Home Nasal Spray Flu Vaccine Increases Accessiblity For Families Read More »


